Inactive Instrument

Company Shire

Equities

JE00B2QKY057

Pharmaceuticals

Business Summary

Shire specializes in developing, producing, and marketing pharmaceutical products for the treatment of nervous system dysfunctions (hyperactivity, epilepsy, Alzheimer's disease, etc.), cancer, gastro-intestinal illnesses, and infectious diseases. Net sales break down by source of income as follows:

- sales of products (95.3%);

- other (4.7%): primarily franchise royalties.

Net sales break down geographically as follows: the United States (63.6%), Ireland (0.4%) and other (36%).

Managers

Managers TitleAgeSince
Director/Board Member - 19-01-07
Corporate Officer/Principal - -
Human Resources Officer - 12-03-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member - 19-01-07
Director/Board Member - 19-01-07
Director/Board Member - 19-01-07
Director/Board Member - 19-01-07
Director/Board Member - 19-01-07
Director/Board Member - 19-01-07

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 925,620,398 0 7,500,000 ( 0.8103 %) -

Company contact information

Shire Plc

Miesian Plaza 50-58 Baggot Street Lower

2, Dublin

+353 1 609 6000

http://www.shire.com
address Shire

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Shire Services BVBA
Pharmaceuticals: Major
Pharmaceuticals: Major
Shire Licensing VOF